Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP

Conditions

• Neoplasms, Unknown Primary

Interventions

• OTHER: Cancer Type ID test
• OTHER: No test Empiric strategy

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

• [object Object]